{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T15:40:10Z","timestamp":1716219610746},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T00:00:00Z","timestamp":1385510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/ejhg.2013.270","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T11:34:15Z","timestamp":1385552055000},"page":"916-922","source":"Crossref","is-referenced-by-count":3,"title":["Genealogical analysis as a new approach for the investigation of drug intolerance heritability"],"prefix":"10.1038","volume":"22","author":[{"given":"Marc","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Bouhali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,27]]},"reference":[{"key":"BFejhg2013270_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.genom.2.1.69","volume":"2","author":"C Scriver","year":"2001","unstructured":"Scriver C : Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2001; 2: 69\u2013101.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BFejhg2013270_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1086\/323659","volume":"69","author":"DL Newman","year":"2001","unstructured":"Newman DL, Abney M, McPeek MS, Ober C, Cox NJ : The importance of genealogy in determining genetic associations with complex traits. Am J Hum Genet 2001; 69: 1146\u20131148.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2013270_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1534\/genetics.108.089912","volume":"179","author":"M Abney","year":"2008","unstructured":"Abney M : Identity-by-descent estimation and mapping of qualitative traits in large, complex pedigrees. Genetics 2008; 179: 1577\u20131590.","journal-title":"Genetics"},{"key":"BFejhg2013270_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosissup.2004.08.026","volume":"suppl. 5","author":"A Endo","year":"2004","unstructured":"Endo A : The discovery and development of HMG-CoA reductase inhibitors. Atherosclerosis 2004; suppl. 5: 67\u201380.","journal-title":"Atherosclerosis"},{"key":"BFejhg2013270_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Baigent C, Blackwell L et al: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet 2010; 376: 1670\u20131681.","journal-title":"Lancet"},{"key":"BFejhg2013270_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","volume":"158","author":"H Zhang","year":"2013","unstructured":"Zhang H, Plutzky J, Skentzos S et al: Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med 2013; 158: 526\u2013534.","journal-title":"Ann Intern Med"},{"key":"BFejhg2013270_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","volume":"106","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC, Bairey-Merz CN et al: ACC\/AHA\/NHLBI Clinical Advisory on the Use and Safety of Statins. Circulation 2002; 106: 1024\u20131028.","journal-title":"Circulation"},{"key":"BFejhg2013270_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","volume":"289","author":"PD Thompson","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH : Statin-associated myopathy. JAMA 2003; 289: 1681\u20131690.","journal-title":"JAMA"},{"key":"BFejhg2013270_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","volume":"27","author":"GB Mancini","year":"2001","unstructured":"Mancini GB, Baker S, Bergeron J et al: Diagnosis, prevention, and management of statin adverse effects and intolerance proceedings of a Canadian Working Group Consensus Conference. Can J Cardiol 2001; 27: 635\u2013662.","journal-title":"Can J Cardiol"},{"key":"BFejhg2013270_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd2423","volume":"6","author":"RA Wilke","year":"2007","unstructured":"Wilke RA, Lin DW, Roden DM et al: Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 2007; 6: 904\u2013916.","journal-title":"Nat Rev Drug Discov"},{"key":"BFejhg2013270_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","volume":"226","author":"A Vuorio","year":"2013","unstructured":"Vuorio A, Docherty KF, Humphries SE, Kuoppala J, Kovanen PT : Statin treatment of children with familial hypercholesterolemia\u2014trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? Atherosclerosis 2013; 226: 315\u2013320.","journal-title":"Atherosclerosis"},{"key":"BFejhg2013270_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/tpj.2010.92","volume":"12","author":"LR Brunham","year":"2012","unstructured":"Brunham LR, Lansberg PJ, Zhang L et al: Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J 2012; 12: 233\u2013237.","journal-title":"Pharmacogenomics J"},{"key":"BFejhg2013270_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/BOR.0b013e328314b7b4","volume":"20","author":"GD Vladutiu","year":"2008","unstructured":"Vladutiu GD : Genetic predisposition to statin myopathy. Curr Opin Rheumatol 2008; 20: 648\u2013655.","journal-title":"Curr Opin Rheumatol"},{"key":"BFejhg2013270_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1365-2710.2012.01337.x","volume":"37","author":"M Francesca Notarangelo","year":"2012","unstructured":"Francesca Notarangelo M, Marziliano N, Antonietta Demola M et al: Genetic predisposition to atorvastatin-induced myopathy: a case report. J Clin Pharm Ther 2012; 37: 604\u2013606.","journal-title":"J Clin Pharm Ther"},{"key":"BFejhg2013270_CR15","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"JL Goldstein","year":"1987","unstructured":"Goldstein JL, Hobbs HH, Brown MS : Familial hypercholesterolemia; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, NY, USA: McGraw-Hill, 1987."},{"key":"BFejhg2013270_CR16","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","volume":"5","author":"PN Hopkins","year":"2011","unstructured":"Hopkins PN, Toth PP, Ballantyne CM, Rader DJ : National Lipid Association Expert Panel on Familial Hypercholesterolemia: familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: S9\u201317.","journal-title":"J Clin Lipidol"},{"key":"BFejhg2013270_CR17","first-page":"113","volume":"17","author":"R Roy","year":"1988","unstructured":"Roy R, Bouchard G, Declos M : La premi\u00e8re g\u00e9n\u00e9ration de Saguenayens: provenance, apparentement, enracinement. Cah Que Demogr 1988; 17: 113\u2013133.","journal-title":"Cah Que Demogr"},{"key":"BFejhg2013270_CR18","unstructured":"Bouchard G : Quelques Arpents d'Am\u00e9rique. Population, \u00e9conomie, famille au Saguenay, 1838\u20131971. Montreal: Boreal, 1996."},{"key":"BFejhg2013270_CR19","unstructured":"Institut de la statistique du Qu\u00e9bec http:\/\/www.stat.gouv.qc.ca\/donstat\/societe\/demographie\/dons_regnl\/regional\/ra_total.htm Accessed 27 March 2013."},{"key":"BFejhg2013270_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1399-0004.2005.00497.x","volume":"68","author":"A-M Laberge","year":"2005","unstructured":"Laberge A-M, Michaud J, Richter A et al: Population history and its impact on medical genetics in Quebec. Clin Genet 2005; 68: 287\u2013301.","journal-title":"Clin Genet"},{"key":"BFejhg2013270_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408363.2011.565585","volume":"48","author":"KE Liyanage","year":"2011","unstructured":"Liyanage KE, Burnett JR, Hooper AJ, van Bockxmeer FM : Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution. Crit Rev Clin Lab Sci 2011; 48: 1\u201318.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"BFejhg2013270_CR22","first-page":"54","volume":"124","author":"D Gaudet","year":"1995","unstructured":"Gaudet D, Tremblay G, Perron P, Gagn\u00e9 C, Ouadahi Y, Moorjani S : L'hypercholest\u00e9rol\u00e9mie familiale dans l'est du Qu\u00e9bec: un probl\u00e8me de sant\u00e9 publique? L'exp\u00e9rience de la clinique des maladies lipidiques de Chicoutimi. Union Med Can 1995; 124: 54\u201360.","journal-title":"Union Med Can"},{"key":"BFejhg2013270_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.1997.tb02506.x","volume":"52","author":"M-C Vohl","year":"1997","unstructured":"Vohl M-C, Moorjani S, Roy M et al: Geographic distribution of French Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec. Clin Genet 1997; 52: 1\u20136.","journal-title":"Clin Genet"},{"key":"BFejhg2013270_CR24","first-page":"99","volume":"71","author":"E Heyer","year":"1999","unstructured":"Heyer E : One founder\/one gene hypothesis in a new expanding population: Saguenay (Quebec, Canada). Hum Biol 1999; 71: 99\u2013109.","journal-title":"Hum Biol"},{"key":"BFejhg2013270_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3917\/pope.303.0361","volume":"58","author":"M Tremblay","year":"2003","unstructured":"Tremblay M, Arsenault J, Heyer E : The transmission probabilities of founder genes in five regional populations of Quebec. Population-E 2003; 58: 361\u2013380.","journal-title":"Population-E"},{"key":"BFejhg2013270_CR26","first-page":"152","volume":"8","author":"EM Lavoie","year":"2005","unstructured":"Lavoie EM, Tremblay M, Houde L, V\u00e9zina H : Demogenetic study of three populations within a region with strong founder effects. Community Genet 2005; 8: 152\u2013160.","journal-title":"Community Genet"},{"key":"BFejhg2013270_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/humu.1380060307","volume":"6","author":"M-C Vohl","year":"1995","unstructured":"Vohl M-C, Couture P, Moorjani S et al: Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians. Hum Mutat 1995; 6: 243\u2013246.","journal-title":"Hum Mutat"},{"key":"BFejhg2013270_CR28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0004.1989.tb03194.x","volume":"36","author":"YH Ma","year":"1989","unstructured":"Ma YH, Betard C, Roy M, Davignon J, Kessling AM : Identification of a second French Canadian LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 1989; 36: 219\u2013228.","journal-title":"Clin Genet"},{"key":"BFejhg2013270_CR29","unstructured":"BALSAC Project: www.uqac.ca\/balsac Accessed 27 March 2013."},{"key":"BFejhg2013270_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ajpa.21424","volume":"144","author":"C Bherer","year":"2011","unstructured":"Bherer C, Labuda D, Roy-Gagnon MH, Houde L, Tremblay M, V\u00e9zina H : Admixed ancestry and stratification of Quebec regional populations. Am J Phys Anthropol 2011; 144: 432\u2013441.","journal-title":"Am J Phys Anthropol"},{"key":"BFejhg2013270_CR31","unstructured":"Lavoie \u00c8M, Jomphe M, Tremblay M, V\u00e9zina H : Sources et proc\u00e9dures de reconstitutions g\u00e9n\u00e9alogiques: RETRO, CARGO, BALSAC. Document no I-C-240, Projet BALSAC, Universit\u00e9 du Qu\u00e9bec \u00e0 Chicoutimi, Chicoutimi, Canada 2011."},{"key":"BFejhg2013270_CR32","first-page":"185","volume":"66","author":"E O\u2019Brien","year":"1994","unstructured":"O\u2019Brien E, Kerber RA, Jorde LB, Rogers AR : Founder effect: assessment of variation in genetic contributions among founders. Hum Biol 1994; 66: 185\u2013204.","journal-title":"Hum Biol"},{"key":"BFejhg2013270_CR33","doi-asserted-by":"publisher","first-page":"l","DOI":"10.1002\/ajpa.1330980102","volume":"98","author":"E Heyer","year":"1995","unstructured":"Heyer E : Genetic consequences of differential demographic behaviour in the Saguenay region, Quebec. Am J Phys Anthropol 1995; 98: l\u201311.","journal-title":"Am J Phys Anthropol"},{"key":"BFejhg2013270_CR34","first-page":"970","volume":"56","author":"E Heyer","year":"1995","unstructured":"Heyer E, Tremblay M : Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet 1995; 56: 970\u2013978.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2013270_CR35","volume-title":"Pedigree Analysis in Human Genetics","author":"EA Thompson","year":"1986","unstructured":"Thompson EA : Pedigree Analysis in Human Genetics. Baltimore, MD, USA: Johns Hopkins University Press, 1986, p 25."},{"key":"BFejhg2013270_CR36","first-page":"209","volume":"69","author":"\u00c9 Heyer","year":"1997","unstructured":"Heyer \u00c9, Tremblay M, Desjardins B : Seventeenth-century European origins of hereditary diseases in the Saguenay population (Quebec, Canada). Hum Biol 1997; 69: 209\u2013225.","journal-title":"Hum Biol"},{"key":"BFejhg2013270_CR37","first-page":"67","volume":"2","author":"H V\u00e9zina","year":"2004","unstructured":"V\u00e9zina H, Tremblay M, Houde L : Mesures de l\u2019apparentement biologique au Saguenay-Lac-St-Jean (Qu\u00e9bec, Canada) \u00e0 partir de reconstitutions g\u00e9n\u00e9alogiques. Ann Demogr Hist 2004; 2: 67\u201384.","journal-title":"Ann Demogr Hist"},{"key":"BFejhg2013270_CR38","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1086\/324024","volume":"69","author":"\u00c9 Heyer","year":"2001","unstructured":"Heyer \u00c9, Zietkiewicz E, Rochowski A, Yotova V, Puymirat J, Labuda D : Phylogenetic and familial estimates of mitochondrial substitution rates: study of control region mutations in deep-rooting pedigrees. Am J Hum Genet 2001; 69: 1113\u20131126.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2013270_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ng1492","volume":"37","author":"A Helgason","year":"2005","unstructured":"Helgason A, Yngvad\u00f3ttir B, Hrafnkelsson B, Gulcher J, Stef\u00e1nsson K : An Icelandic example of the impact of population structure on association studies. Nat Genet 2005; 37: 90\u201395.","journal-title":"Nat Genet"},{"key":"BFejhg2013270_CR40","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/2009.10.FOCUS09214","volume":"28","author":"TN Niazi","year":"2010","unstructured":"Niazi TN, Cannon-Albright LA, Couldwell WT : Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases. Neurosurg Focus 2010; 28: E1.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2013270_CR41","volume-title":"Human Population Genetics: Evolution and Variation. The Biomedical & Life Sciences Collection","author":"B Brais","year":"2007","unstructured":"Brais B, Desjardins B, Labuda D, St-Hilaire M, Tremblay M, V\u00e9zina H : The genetics of French Canadians; in Cavalli-Sforza L, Feldman M (eds): Human Population Genetics: Evolution and Variation. The Biomedical & Life Sciences Collection. London, UK: Henry Stewart Talks Ltd, 2007."},{"key":"BFejhg2013270_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.clpt.2005.08.003","volume":"78","author":"M Fiegenbaum","year":"2005","unstructured":"Fiegenbaum M, da Silveira FR, Van der Sand CR et al: The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin Pharmacol Ther 2005; 78: 551\u2013558.","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013270","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T15:19:59Z","timestamp":1716218399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2013270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,27]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFejhg2013270"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2013.270","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,27]]}}}